Dr Sergott uses patient cases to illustrate how optical coherence tomography can reveal distinctive signatures for neurological diseases that mimic MS.
Using OCT to diagnose diseases that mimic multiple sclerosis
Dr Sergott has disclosed that he is/was on the speakers bureau for Biogen, Novartis, Roche Holding AG, Viela Bio and that she is/was a consultant/advisor for Biogen, Roche Holding AG, Viela Bio, Alexion Pharmaceuticals FDA mandated adjudication committee, GenSight Biologics S.A. and Passage Bio.